iiinova — where your digital self keeps evolving

Vibe Bio @vibebio.bsky.social · 24/09/2025

📅 Today's the day! Register now to join us at 1 PM ET to get a practical, executive-level framework to evaluate AI solutions for BD&L teams. You’ll learn: 📷 Which features matter most 📷 A framework to evaluate vendors 📷 #biopharma hubs.ly/Q03HbtX-0 #AI #bizdev

Webinar: The AI buyer's guide for BD&L executives. Learn how to evaluate and choose AI solutions to achieve real results in biopharma

000

Vibe Bio @vibebio.bsky.social · 09/09/2025

Join us for an educational session on September 24 at 1 PM ET. We'll walk through an executive-level framework for evaluating AI solutions for BD&L teams. You’ll learn: > AI adoption & risks > Build, buy, or partner options > Types/tradeoffs of existing solutions vibebio.com/resources/ev...

000

Vibe Bio @vibebio.bsky.social · 28/05/2025

⏳ In ~30 minutes: join our live webinar on how #AI is streamlining #biopharma #businessdevelopment. Learn: – Best practices from top BD teams – Industry shifts driving demand for in-licensing – How AI helps prioritize, benchmark, and diligence assets at scale Tune in: vibebio.com/resources/ev...

Bottlenecks to breakthroughs: How AI is reshaping biopharma BD&L
Webinar: May 28, 1 PM ET
(Available on demand shortly thereafter)

000

Vibe Bio @vibebio.bsky.social · 03/03/2025

#Chinese #biopharma companies are at an inflection point, with rapidly advancing in science, know-how, and talent. Chinese assets are poised to reshape #drugdevelopment. How will this impact the industry as a whole? Learn more in this post by Alok Tayi, PhD: vibebio.com/blog/great-d...

Image for blog post meant to communicate "The Great Disruption: how Chinese assets will reshape drug development
"

000

Vibe Bio @vibebio.bsky.social · 18/02/2025

#AI is revolutionizing #businessdevelopment in #biopharma. Join our Founder & CEO, Alok Tayi, PhD, tomorrow (Feb 19, 1 PM ET) for a #webinar on how #AI is speeding up decision-making, streamlining #drugassetevaluation, and improving #programsourcing and #duediligence. vibebio.com/resources/ev...

[Upcoming Webinar ] Biopharma BD meets Al: Accelerating due diligence to find the right assets Wednesday | February 19th | 1PM ET

Register today!

Alok Tayi, Ph.D. Co-Founder & CEO

010

Vibe Bio @vibebio.bsky.social · 05/02/2025

Hey! Don't miss Alok Tayi, PhD, our Founder & CEO! #Webinar on Feb 19 @ 1 PM ET for a on how #AI is transforming Biopharma #businessdevelopment & accelerating due diligence. Topics: In-licensing complexity AI-driven search & evaluation Leadership & AI synergy Register: vibebio.com/resources/ev...

Biopharma BD meets AI - webinar 2/19/25 at 1 PM ET with Vibe Bio CEO and Founder, Alok Tayi, PhD

010

Vibe Bio @vibebio.bsky.social · 16/01/2025

Enjoyed our discussion on the investor panel yesterday at #JPM2025. Many thanks to Elena Itskovich, PhD - Nest Catalyst Ventures Founder + GP, Alok Tayi, PhD - Vibe Bio Co-founder + CEO, Manuel Grossmann - Amino Collective General Partner, and Omri Drory, Phs - NFX Bio General Partner. #biotech

Investor panel at JPM 2025:

Elena Itskovich, PhD - Nest Catalyst Ventures Founder and GP.

Alok Taki, PhD - Vibe Bio Co-founder and CEO

Manuel Grossman - Amino Collective General Partner

Omri Amirav-Drory, PhD - NFX Bio General Partner

011

Vibe Bio @vibebio.bsky.social · 05/12/2024

Join Alok Tayi, PhD + Andy Birch for a #webinar Dec 18 at 1PM ET to learn how AI-powered #pipelineanalysis is changing the game in #pharma! Key Takeaways: > Overcoming challenges in #drugdevelopment > Speeding up decisions with #AI > The role of human expertise Register: vibebio.com/resources/ev...

An image that says:
Vibe Bio—Unlock Smarter Drug Development Decisions with AI on Wednesday, December 18th at 1 PM ET - Register Today

110